How long does one box of filgotinib last and how long is the period of use?

Filgotinib is an oral medication widely used to treat moderately to severely active rheumatoid arthritis and moderately to severely active ulcerative colitis (UC). The dosage is 200mg, taken orally once daily, and usually packaged in a box of 30 tablets. Therefore, the usage period of a box of medicine is one month, and the specific time may change due to individual differences among patients, doctor's recommendations, and adjustments to the treatment plan.

During the treatment process, the method of taking filgotinib is usually relatively simple. Once a day, it is not affected by meal times. Patients can choose to take it at any time according to their own living habits. Because filgotinib is a long-term treatment drug, its effects usually take some time to appear. At the beginning of treatment, patients may gradually feel the effects of the medication over weeks to months, relieving symptoms, reducing inflammation, and improving joint and intestinal function.

For people with rheumatoid arthritis, filgotinib can help reduce joint inflammation, reduce pain, and improve function, while for people with ulcerative colitis, the drug can reduce intestinal inflammation and reduce symptoms such as abdominal pain and diarrhea. However, the period of use of filgotinib not only depends on the course of treatment of the drug itself, but should also be adjusted according to changes in the patient's condition. If the patient's condition is effectively controlled after treatment with filgotinib, the doctor may recommend continuing maintenance treatment or even reducing the drug dose in some cases.

Patients should undergo regular reexamination during treatment to monitor efficacy and side effects to ensure the safety of the drug. Generally, long-term treatment with filgotinib is safe, but patients should strictly follow the doctor's instructions during treatment and avoid adjusting the medication plan on their own.

Keyword tags: filgotinib, usage cycle,200mg, once daily, rheumatoid arthritis, ulcerative colitis

Reference materials:https://www.ema.europa.eu/en/medicines/human/EPAR/jyseleca